Diabetic Nephropathy Therapeutics Market Pipeline Review, H2
2017
“Pharmaceutical and Healthcare disease pipeline guide Diabetic
Nephropathy - Pipeline Review, H2 2017, provides an overview of the
Diabetic Nephropathy (Metabolic Disorders) pipeline landscape.”
Summary
Pharmaceutical and Healthcare disease pipeline guide Diabetic Nephropathy - Pipeline Review, H2 2017,
provides an overview of the Diabetic Nephropathy (Metabolic Disorders) pipeline landscape.
Diabetic nephropathy is the damage to the kidney occurring due to diabetes. It is characterized by
albuminuria, reduction in glomerular filtration rate and high blood pressure. Risk factors include obesity,
hypertension, high lipid and sugar levels and smoking. This condition is managed by medication and dietary
modification.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Diabetic Nephropathy - Pipeline Review, H2 2017,
provides comprehensive information on the therapeutics under development for Diabetic Nephropathy
(Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action
(MoA), route of administration (RoA) and molecule type.
Browse Detail Report With TOC @
https://www.hexareports.com/report/diabetic-nephropathy-pipeline-review-h2-2017
Follow Us: